Nisa Investment Advisors
KERX

Nisa Investment Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Nisa Investment Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,010
Closed -$3K – 2005
2018
Q3 		$3K Sell
1,010
-440
-30% -$1.59K ﹤0.01% 1947
2018
Q2 		$5K Hold
1,450
– – ﹤0.01% 1841
2018
Q1 		$6K Sell
1,450
-150
-9% -$698 ﹤0.01% 1785
2017
Q4 		$7K Sell
1,600
-13,500
-89% -$74.4K ﹤0.01% 1798
2017
Q3 		$107K Buy
15,100
+13,500
+844% +$97.1K ﹤0.01% 1358
2017
Q2 		$12K Buy
1,600
+300
+23% +$1.88K ﹤0.01% 1673
2017
Q1 		$8K Sell
1,300
-300
-19% -$1.64K ﹤0.01% 1745
2016
Q4 		$9K Sell
1,600
-900
-36% -$4.92K ﹤0.01% 1824
2016
Q3 		$13K Hold
2,500
– – ﹤0.01% 1764
2016
Q2 		$17K Buy
2,500
+100
+4% +$559 ﹤0.01% 1683
2016
Q1 		$11K Buy
+2,400
New +$9.58K ﹤0.01% 1769

Nisa Investment Advisors's KERX Position: Q4 2018 in Review

Nisa Investment Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 1,010 shares — an estimated $3K sold.

Nisa Investment Advisors first reported a position in KERX in Q1 2016 and held it in 11 quarters. The position peaked at $107K in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Nisa Investment Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,010 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $3K.
  • Nisa Investment Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q1 2016 and held it in 11 quarters.
  • Nisa Investment Advisors's Keryx Biopharmaceuticals Inc position peaked at $107K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Nisa Investment Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.